Skip to main content
Year archive

CLEVER CULTURE SYSTEMS LIMITED — 2019 filings

All 57 regulatory filings released by CLEVER CULTURE SYSTEMS LIMITED (CC5) in 2019, sourced directly from the official regulator.

57 Filings
2019 Period
2019 filings (57)
Filing Released Lang
Change of Director's Interest Notice 2 pages 155.4KB
Director's Dealing
2019-12-11 English
Change of Director's Interest Notice 2 pages 155.2KB
Director's Dealing
2019-12-10 English
Appendix 3B 13 pages 373.0KB
Share Issue/Capital Change
2019-12-09 English
Appendix 3B 13 pages 370.6KB
Share Issue/Capital Change
2019-11-27 English
Chairman's Address to Shareholders 2 pages 108.1KB
AGM Information
2019-11-26 English
CEO Presentation - AGM 2019 11 pages 1.5MB
AGM Information
2019-11-26 English
Results of Meeting 3 pages 101.2KB
Declaration of Voting Results & Voting Rights Announcements
2019-11-26 English
Appendix 3B 13 pages 372.9KB
Capital/Financing Update
2019-11-13 English
Presentation at Australia Biotech Invest & Partnering 2019 1
Investor Presentation
2019-10-30 English
Non-Executive Director Retirement 1 page 126.5KB
Board/Management Information
2019-10-29 English
Final Director's Interest Notice 2 pages 137.9KB
Director's Dealing
2019-10-29 English
Appendix 4C - quarterly 8 pages 307.9KB
Interim / Quarterly Report
2019-10-24 English
Notice of Annual General Meeting/Proxy Form 32 pages 369.9KB
AGM Information
2019-10-21 English
LBT Presents at Australian Microcap Investment Conference 1
Regulatory Filings
2019-10-20 English
First European Sale of APAS Independence 2 pages 143.7KB
Capital/Financing Update
2019-10-20 English
Annual Report to shareholders 72 pages 3.4MB
Annual Report
2019-09-29 English
Corporate Governance Statement 10 pages 244.6KB
Governance Information
2019-09-29 English
Appendix 4G 13 pages 252.1KB
Governance Information
2019-09-29 English
LBT Presents at ExchangeSA Conference in Adelaide 17 pages 2.4MB
Investor Presentation
2019-09-25 English
MRSA Analysis Module CE Mark Registration 2 pages 132.1KB
Capital/Financing Update
2019-09-24 English
European Union Regulatory Certification & MRSA Study Results 2 pages 144.5KB
Regulatory Filings
2019-09-15 English
LBT Presents at ASX Small & Microcap Conference 1 p
Investor Presentation
2019-09-04 English
Appendix 4E Full Year Report 2 pages 127.7KB
Annual Report
2019-08-28 English
Full Year Statutory Accounts 51 pages 1.2MB
Annual Report
2019-08-28 English
Change of Director's Interest Notice 2 pages 141.0KB
Director's Dealing
2019-08-06 English
Appendix 4C - quarterly 8 pages 300.4KB
Interim / Quarterly Report
2019-07-28 English
Timing of Quarterly Results & Investor Call 1 page
Investor Presentation
2019-07-24 English
Update on Distributor Appointments 2 pages 137.1KB
Capital/Financing Update
2019-07-21 English
Share Trading Policy 5 pages 213.3KB
Governance Information
2019-06-27 English
South Australian Government Loan $1.5M Drawdown 1 p
Capital/Financing Update
2019-06-26 English
First U.S. Clinical Data with APAS Presented at ASM Microbe 3 pages 658.4KB
Investor Presentation
2019-06-23 English
US Market Update 2 pages 130.4KB
Regulatory Filings
2019-06-18 English
Appendix 3B 13 pages 382.1KB
Share Issue/Capital Change
2019-06-10 English
Information Required Under ASX Listing Rule 3.10.5A 1
Capital/Financing Update
2019-06-10 English
Notice under Section 708A 1 page 83.6KB
Capital/Financing Update
2019-06-10 English
$5M Oversubscribed Private Placement 25 pages 1.5MB
Capital/Financing Update
2019-06-04 English
Trading Halt 2 pages 301.9KB
Capital/Financing Update
2019-06-02 English
APAS Independence Receives US FDA 510(k) Clearance 4 pages 454.4KB
Capital/Financing Update
2019-05-19 English
Trading Halt 2 pages 163.3KB
Regulatory Filings
2019-05-16 English
AusMedtech & ANDHealth Conferences 1 page 127.6KB
Regulatory Filings
2019-05-14 English
South Australian Government Loan - $1.0M Drawdown 1
Capital/Financing Update
2019-05-08 English
Business Update Presentation 27 pages 2.7MB
Investor Presentation
2019-04-29 English
Appendix 4C - quarterly 8 pages 298.8KB
Interim / Quarterly Report
2019-04-28 English
Timing of Quarterly Results & Investor Call 1 page
Investor Presentation
2019-04-23 English
APAS Independence MRSA Study Results Presented at ECCMID 3 pages 306.5KB
Regulatory Filings
2019-04-14 English
MRSA Analysis Module - Clinical Study Commenced 2 pages 131.9KB
Regulatory Filings
2019-04-01 English
Change of Director's Interest Notice 2 pages 143.1KB
Director's Dealing
2019-03-31 English
Initial Director's Interest Notice 2 pages 183.9KB
Director's Dealing
2019-03-24 English
Change of Director's Interest Notice 2 pages 145.3KB
Director's Dealing
2019-03-21 English
Change of Director's Interest Notice 2 pages 140.0KB
Director's Dealing
2019-03-03 English
Final Director's Interest Notice 2 pages 130.4KB
Director's Dealing
2019-03-03 English
Non-Executive Director Changes 1 page 127.0KB
Board/Management Information
2019-02-28 English
Half Yearly Report and Accounts 20 pages 726.8KB
Interim / Quarterly Report
2019-02-25 English
Details of Investor Call - 6 February 2019 1 page 1
Call Transcript
2019-02-04 English
Initial Director's Interest Notice 2 pages 183.1KB
Director's Dealing
2019-02-03 English
Appendix 4C - quarterly 8 pages 301.2KB
Interim / Quarterly Report
2019-01-30 English
Appointment US Based Non-Executive Director Simon Arkell 2 pages 132.2KB
Board/Management Information
2019-01-29 English